Besides Sanofi deal for nuvaxovid, Novavax has few opportunities to generate additional revenue, which likely means its stock ...

If you missed the early fall push for flu and COVID-19 vaccines, it's not too late. Health officials say it's important to ...

These are the three vaccines that are currently updated and available for use in the U.S.: Moderna’s Spikevax mRNA vaccine Pfizer-BioNTech’s Comirnaty vaccine Novavax’s NVX-CoV2705 vaccine ...

On Monday, the FDA granted full approval to Moderna's vaccine, which will be marketed as Spikevax, for adults. Meanwhile Novavax -already approved by Europe's EMA- has filed for FDA clearance.

Novavax's traditional protein-based shot offers an alternative vaccine technology to those that are based on messenger RNA - ...

The FDA has approved new versions of Pfizer/BioNTech's Comirnaty and Moderna's Spikevax COVID-19 vaccines ... A third player in the market, Novavax, filed for approval of a non-mRNA vaccine ...

Vaccines are a critical tool for preventing the spread of COVID-19 and protecting against severe illness and death. But questions and concerns about the vaccines still abound. This guide, with ...

An updated version of Novavax’s COVID-19 vaccine has been ... Health Canada also authorized an updated Moderna COVID-19 vaccine, called Spikevax, which has been reformulated to target the ...

The fall booster shot will protect against some of the latest strains of the virus, including JN. 1 and KP. 2, Health Canada ...

US FDA pauses Novavax's trial of combo COVID-flu shot ... in messenger RNA technology with its blockbuster COVID-19 vaccine Spikevax and RSV shot mResvia. Pfizer and its German partner BioNTech ...

Novavax's traditional protein-based shot offers an alternative vaccine technology to those that are based on messenger RNA - Moderna's Spikevax and Comirnaty, which is jointly developed by Pfizer and ...